|1.||Mejía, Miguel Eduardo: 1 article (03/2005)|
|2.||Lacau-Mengido, Isabel María: 1 article (03/2005)|
|3.||Majumdar, A C: 1 article (10/2002)|
|4.||Srivastava, S K: 1 article (10/2002)|
|5.||Selvaraju, S: 1 article (10/2002)|
|6.||Agarwal, S K: 1 article (10/2002)|
|7.||Karche, S D: 1 article (10/2002)|
|8.||Shanker, U: 1 article (10/2002)|
|9.||Tischer, M: 1 article (03/2000)|
|10.||Heuwieser, W: 1 article (03/2000)|
03/15/2005 - "In conclusion, treatment with tiaprost impaired reproductive performance in primiparous cows (in the absence of endometritis). "
03/15/2005 - "The objective of Experiment 3 was to determine the effects of tiaprost treatment on clinically normal postpartum cows (no evidence of endometritis). "
03/15/2005 - "In Experiment 1, half of the cows diagnosed with endometritis (>1.5-fold difference in diameter of uterine horns, as determined by rectal palpation) received standard endometritis management (treatment with tiaprost, a PGF(2alpha) analog, rectal palpation every 20 days, and withholding of AI until endometritis apparently resolved) and the other half was untreated, with AI at the first estrus after the voluntary waiting period. "
03/18/2000 - "A total of 542 cows were examined for endometritis 22 to 28 days postpartum and assigned to one of three treatment groups: in group 1 the cows with signs of endometritis were treated with an intrauterine infusion of 100 ml of a 2 per cent polycondensated m-cresolsulphuric acid formaldehyde solution; in group 2 the cows with signs of endometritis were treated with an intrauterine infusion of 125 ml of a 20 per cent eucalyptus compositum solution; and in group 3 all the cows were injected intramuscularly with 0.75 mg of tiaprost, an analogue of prostaglandin F2alpha (PGF2alpha) at two-week intervals, starting on day 43, until they were inseminated. "
|2.||Body Weight (Weight, Body)
|1.||Prostaglandins F (PGF)